rdca-dap: how the data and analytics platform accelerates rare disease drug development
Published 3 years ago • 43 plays • Length 8:03Download video MP4
Download video MP3
Similar videos
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
58:49
webinar: how rdca-dap can help inform optimal trial design in progressive rare disease
-
4:12
why are high-quality standardized databases so critical for drug development?
-
53:31
ai-powered real-world simulations for faster and value-based rare disease drug development
-
3:48
how has the presence or lack of data changed drug development for platelet disorders?
-
55:49
sharing data with rdca-dap: your questions answered
-
54:44
how to pandemic proof your business webinar - april 2020
-
12:12
the 6 rare diseases changing modern medicine
-
5:09
how are pharmaceutical companies using artificial intelligence?
-
58:44
shortening the timeline for developing new treatments - how the rdca-dap can help
-
31:11
from data to cures: speeding the way for rare diseases
-
12:03
rdca-dap drug development tool prototypes
-
4:17
rdca-dap: shortening the timeline for developing new treatments for rare diseases
-
59:38
generating synthetic longitudinal data
-
57:06
the role of integrated datasets in addressing rare diseases research challenges
-
4:07
what is exciting to you about taking on this ambitious project?
-
1:34:43
eatx rdca-dap - webinar on ‘data sharing and analysis to support rare disease drug development‘
-
24:22
2022 rdca-dap workshop: case study 3, duchenne regulatory science consortia (d-rsc)